NEW YORK (GenomeWeb) – Shares of firms operating in the molecular diagnostics and omics spaces reversed losses suffered in September as the GenomeWeb Daily News Index rose nearly 8 percent month over month in October.

Several firms in the MDx/omics arena saw sharp jumps in their share prices last month, led by Foundation Medicine, whose stock value increased more than 36 percent month over month, while Pacific Biosciences' share price was up almost 34 percent, and Genomic Health saw its share price rise 28 percent.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

Researchers find that a personalized medicine approach could help people who experience pain while taking statins, New Scientist reports.

US National Science Foundation is continuing its responsible research conduct training policy despite its flaws, ScienceInsider reports.

A CRISPR-themed meeting explored how the tool could and should be used, Wired reports.

In Science this week: database of proteins' effects on cancer, targeted error correction sequencing, and more.